You are here

Responses

Article menu
Download PDFPDF
Community child health, public health, and epidemiology
Nasal/buccal midazolam use in the community
Compose a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on: 22 March 2016
    Community use of buccal midazolam
    • Jane L Dunlop, Paediatric Specialist Registrar
    • Other Contributors:
      • Andrew W McNinch

    Dear Editor

    This report is welcome in providing data on the important subject of buccal midazolam use in the community. Confidence in the results would be increased by clarification of the following points:

    First, might the parents have been biased in favour of midazolam by the package of education and discussion about potential benefits which preceded the midazolam usage?

    Second,it would be...

    Show More
    Conflict of Interest:
    None declared.
  • Published on: 22 March 2016
    Precautions with buccal/nasal midazolam
    • Sudhir Kumar, Consultant Neurologist, Department of Neurological Sciences

    Dear Editor

    I read with great interest the recent article entitled "nasal/buccal midazolam use in the community".[1] However, I would like to point out a few precautions.

    Wilson et al. have used nasal/buccal midazolam for prolonged seizures including status epilepticus. However, in a recent study,[2] the efficacy of buccal midazolam in treating status epilepticus was found to be only 50% and convuls...

    Show More
    Conflict of Interest:
    None declared.
  • Published on: 22 March 2016
    Buccal midazolam

    This seems to be a reasonable alternate to rectal diazepam, however there is a diffrence in the setting where both can be compare. In the hand of medical and paramedical personnel, buccal Midazolam will be more easier to use but the rectal diazepam suppository is more handy and user friendly if to be used by lay person or the parents.

    Conflict of Interest:
    None declared.